ANDAORALTABLET
Approved
Feb 2015
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
2/8 — Basic
METAXALONE (metaxalone) by Colorado Therapeutics is metaxalone's mechanism of action has not been fully characterized, but may be related to its sedative properties. First approved in 2015.
Drug data last refreshed 18h ago
Mechanism of Action
Metaxalone's mechanism of action has not been fully characterized, but may be related to its sedative properties. Metaxalone has no direct action on the contractile mechanism of striated muscle, the motor end plate, or the nerve fiber.
Pharmacologic Class:
Muscle Relaxant
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
Colorado Therapeutics
Worked on METAXALONE at Colorado Therapeutics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.